Effects of cirrhosis on kinetics of aztreonam.
Aztreonam was administered as a single, 3-min, 1-g intravenous infusion to 18 subjects, including 6 with biopsy-proven, primary biliary cirrhosis, 6 with biopsy-proven, stable alcoholic cirrhosis, and 6 age- and sex-matched control subjects with normal hepatic functions. Aztreonam was well tolerated...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1984
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC179951/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6542764/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.26.4.493 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|